As the year comes to a close, many of us naturally pause to reflect. What worked? What didn’t? What needs adjusting before we ...

People with psoriatic arthritis are at higher risk of catching certain infections — and having more severe symptoms. Vaccines can help keep you safe.

Manual labor employees face elevated arthritis risk long before symptoms appear, but early ergonomic intervention, task redesign and evidence-based prevention strategies can protect joint health, ...

Background: Juvenile Idiopathic Arthritis (JIA) is the most common chronic arthritis in children, causing significant joint inflammation and complications. This study evaluates the incidence, ...

Your hands and nails can offer warning signs of underlying disease and even chronic conditions like arthritis or psoriasis. Dr Sood shares 5 signs.

Please provide your email address to receive an email when new articles are posted on . CHICAGO — The novel, oral tyrosine kinase 2 inhibitor deucravacitinib yielded durable ACR20 response rates ...

There is no one defining symptom of PsA, and you may experience more than one symptom at once. Early signs can include joint pain and stiffness, along with changes to your fingernails or red, scaly ...

Foot pain is a common symptom in patients across all ages and is often related to mechanical causes, fatigue, altered foot biomechanics in patients with anatomical conditions such as flat foot, ...

Some people with psoriatic arthritis (PsA) may have disease that is difficult to manage (D2M) or does not respond to treatment. EULAR - The European Alliance of Associations for Rheumatology - has ...

Patients with psoriatic arthritis (PsA) treated with biologics had lower rates of cardiovascular events and all-cause and cardiovascular mortality but a higher risk for infection-related admissions ...

A new treatment for a debilitating inflammatory condition which affects joints and skin has shown promising early results in an international clinical trial of more than 200 patients worldwide.

Deucravacitinib significantly improved joint and skin symptoms, disease activity, and quality of life in psoriatic arthritis patients. The trials demonstrated sustained clinical responses through 52 ...